Goldman Sachs’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-38,802
Closed -$190K 5846
2021
Q3
$190K Sell
38,802
-25,254
-39% -$124K ﹤0.01% 4886
2021
Q2
$338K Buy
64,056
+39,147
+157% +$207K ﹤0.01% 4637
2021
Q1
$120K Sell
24,909
-13,836
-36% -$66.7K ﹤0.01% 4983
2020
Q4
$168K Sell
38,745
-15,453
-29% -$67K ﹤0.01% 4330
2020
Q3
$223K Sell
54,198
-49,044
-48% -$202K ﹤0.01% 4025
2020
Q2
$265K Buy
103,242
+16,090
+18% +$41.3K ﹤0.01% 3882
2020
Q1
$252K Sell
87,152
-7,958
-8% -$23K ﹤0.01% 3848
2019
Q4
$361K Sell
95,110
-90,496
-49% -$343K ﹤0.01% 3795
2019
Q3
$949K Sell
185,606
-1,980
-1% -$10.1K ﹤0.01% 3281
2019
Q2
$1.16M Buy
187,586
+73,344
+64% +$455K ﹤0.01% 3102
2019
Q1
$812K Buy
114,242
+18,950
+20% +$135K ﹤0.01% 3358
2018
Q4
$814K Buy
95,292
+2,533
+3% +$21.6K ﹤0.01% 3218
2018
Q3
$1.86M Buy
92,759
+65,024
+234% +$1.3M ﹤0.01% 2920
2018
Q2
$716K Sell
27,735
-77,134
-74% -$1.99M ﹤0.01% 3363
2018
Q1
$2.51M Sell
104,869
-67,215
-39% -$1.61M ﹤0.01% 2748
2017
Q4
$5.83M Buy
172,084
+70,653
+70% +$2.39M ﹤0.01% 2209
2017
Q3
$2.15M Buy
101,431
+44,492
+78% +$942K ﹤0.01% 2840
2017
Q2
$996K Sell
56,939
-3,958
-6% -$69.2K ﹤0.01% 3151
2017
Q1
$1.07M Buy
60,897
+41,436
+213% +$725K ﹤0.01% 3065
2016
Q4
$329K Buy
19,461
+4,430
+29% +$74.9K ﹤0.01% 3669
2016
Q3
$247K Buy
15,031
+2,537
+20% +$41.7K ﹤0.01% 3803
2016
Q2
$189K Buy
+12,494
New +$189K ﹤0.01% 3886
2016
Q1
Sell
-10,749
Closed -$304K 4660
2015
Q4
$304K Sell
10,749
-5,403
-33% -$153K ﹤0.01% 3505
2015
Q3
$270K Buy
16,152
+6,215
+63% +$104K ﹤0.01% 3664
2015
Q2
$261K Buy
+9,937
New +$261K ﹤0.01% 3829
2015
Q1
Sell
-11,567
Closed -$201K 4675
2014
Q4
$201K Sell
11,567
-2,421
-17% -$42.1K ﹤0.01% 3967
2014
Q3
$260K Sell
13,988
-3,741
-21% -$69.5K ﹤0.01% 3758
2014
Q2
$324K Buy
+17,729
New +$324K ﹤0.01% 3629